[Immunophilin FKBP38, an inherent inhibitor of calcineurin, targets Bcl-2 to mitochondria and inhibits apoptosis].
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics*; D065095:Calcineurin Inhibitors; D045304:Cytochromes c / Q000378:metabolism; D003864:Depression, Chemical; D006801:Humans; D008928:Mitochondria / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000494:pharmacology / Q000502:physiology; D022021:Tacrolimus Binding Proteins / Q000494:pharmacology / Q000502:physiology*; D051020:bcl-X Protein
C494811:BCL2L1 protein, human; D065095:Calcineurin Inhibitors; C471205:FKBP8 protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D051020:bcl-X Protein; D045304:Cytochromes c; D022021:Tacrolimus Binding Proteins